September 2016 - Bioscience Americas

September 2016

Bioscience Americas Announces New Cellular Immunotherapy Treatment

Bioscience Americas, LLC, the leading international developer of autologous stem cell treatment centers, is pleased to announce that it has added cellular immunotherapy for the treatment of cancer to its list of therapies available to patients at its Hospital treatment center in Rionegro, Antioquia, Colombia. Cellular immunotherapy is an innovative new technology developed in the laboratories of Bioscience Americas by its science partner, the Global Institute of Stem Cell Therapy and Research (GIOSTAR). The treatment represents a break-through [...]

Drug Prices Keep Rising

From the campaign trail to the halls of Congress, drug makers have spent much of the last year enduring withering criticism over the rising cost of drugs. It doesn’t seem to be working. In April alone, Johnson & Johnson raised its prices on several top-selling products, including the leukemia drug Imbruvica, the diabetes treatment Invokana, and Xarelto, an anti-clotting drug, according to a research note published last week by an analyst for Leerink, an investment bank. Other major companies that have [...]